Korro Bio is trading now at $10.61, with a -10.08% change after falling from its September 17 close of $11.80; no verified company-specific announcement or filing explains the September 18 decline.
- The latest confirmed disclosure was a September 11 inducement grant covering 5,000 stock options for three new employees; it does not directly explain today’s selling.
- Biotech stocks are broadly stronger, making sector weakness an unlikely explanation.